232 related articles for article (PubMed ID: 21607190)
1. In-vivo Effectiveness of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel on Antibiotic-sensitive and Resistant Propionibacterium acnes.
Leyden JJ; Preston N; Osborn C; Gottschalk RW
J Clin Aesthet Dermatol; 2011 May; 4(5):22-6. PubMed ID: 21607190
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic-resistant Propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%.
Leyden JJ; Wortzman M; Baldwin EK
Cutis; 2008 Dec; 82(6):417-21. PubMed ID: 19181031
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
Cunliffe WJ; Holland KT; Bojar R; Levy SF
Clin Ther; 2002 Jul; 24(7):1117-33. PubMed ID: 12182256
[TBL] [Abstract][Full Text] [Related]
4. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne.
Ozolins M; Eady EA; Avery A; Cunliffe WJ; O'Neill C; Simpson NB; Williams HC
Health Technol Assess; 2005 Jan; 9(1):iii-212. PubMed ID: 15588555
[TBL] [Abstract][Full Text] [Related]
5. The combination formulation of clindamycin 1% plus benzoyl peroxide 5% versus 3 different formulations of topical clindamycin alone in the reduction of Propionibacterium acnes. An in vivo comparative study.
Leyden J; Kaidbey K; Levy SF
Am J Clin Dermatol; 2001; 2(4):263-6. PubMed ID: 11705253
[TBL] [Abstract][Full Text] [Related]
6. Effect of topical benzoyl peroxide/clindamycin versus topical clindamycin and vehicle in the reduction of Propionibacterium acnes.
Leyden JJ
Cutis; 2002 Jun; 69(6):475-80. PubMed ID: 12078851
[TBL] [Abstract][Full Text] [Related]
7. Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years.
Keating GM
Am J Clin Dermatol; 2011 Dec; 12(6):407-20. PubMed ID: 21967116
[TBL] [Abstract][Full Text] [Related]
8. Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris.
Del Rosso JQ
J Drugs Dermatol; 2007 Jun; 6(6):616-22. PubMed ID: 17668527
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of clindamycin and benzoyl peroxide for in vivo suppression of Propionibacterium acnes.
Gans EH; Kligman AM
J Dermatolog Treat; 2002 Sep; 13(3):107-10. PubMed ID: 12227872
[TBL] [Abstract][Full Text] [Related]
10. The development of antibiotic resistance in Propionibacterium acnes.
Leyden J; Levy S
Cutis; 2001 Feb; 67(2 Suppl):21-4. PubMed ID: 11236211
[TBL] [Abstract][Full Text] [Related]
11. Are 2 combined antimicrobial mechanisms better than 1 for the treatment of acne vulgaris? Clinical and antimicrobial results of a topical combination product containing 1% clindamycin and 5% benzoyl peroxide. Introduction.
Leyden J
Cutis; 2001 Feb; 67(2 Suppl):5-7. PubMed ID: 11236213
[TBL] [Abstract][Full Text] [Related]
12. The Tolerability Profile of Clindamycin 1%/Benzoyl Peroxide 5% Gel vs. Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel for Facial Acne: Results of Two Randomized, Single-Blind, Split-Face Studies.
Green L; Cirigliano M; Gwazdauskas JA; Gonzalez P
J Clin Aesthet Dermatol; 2012 May; 5(5):16-24. PubMed ID: 22808305
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of benzoyl peroxide (5.3%) emollient foam and benzoyl peroxide (8%) wash in reducing Propionibacterium acnes on the back.
Leyden JJ
J Drugs Dermatol; 2010 Jun; 9(6):622-5. PubMed ID: 20645523
[TBL] [Abstract][Full Text] [Related]
14. Comparative Trial of Silver Nanoparticle Gel and 1% Clindamycin Gel when Use in Combination with 2.5% Benzoyl Peroxide in Patients with Moderate Acne Vulgaris.
Jurairattanaporn N; Chalermchai T; Ophaswongse S; Udompataikul M
J Med Assoc Thai; 2017 Jan; 100(1):78-85. PubMed ID: 29911775
[TBL] [Abstract][Full Text] [Related]
15. Anti-Inflammatory Dose Doxycycline Plus Adapalene 0.3% and Benzoyl Peroxide 2.5% Gel for Severe Acne.
Kircik LH
J Drugs Dermatol; 2019 Sep; 18(9):924-927. PubMed ID: 31524349
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia.
Ross JI; Snelling AM; Eady EA; Cove JH; Cunliffe WJ; Leyden JJ; Collignon P; Dréno B; Reynaud A; Fluhr J; Oshima S
Br J Dermatol; 2001 Feb; 144(2):339-46. PubMed ID: 11251569
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of VB-1953 Topical Gel in Non-Responder Acne Patients with Clindamycin-Resistant Cutibacterium acnes.
Batra R; Sadhasivam S; Saini S; Gupta S; Bisen RKS; Sinha M; Ghosh S; Jain S
Drugs R D; 2020 Jun; 20(2):95-104. PubMed ID: 32222937
[TBL] [Abstract][Full Text] [Related]
18. The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria.
Eady EA; Bojar RA; Jones CE; Cove JH; Holland KT; Cunliffe WJ
Br J Dermatol; 1996 Jan; 134(1):107-13. PubMed ID: 8745894
[TBL] [Abstract][Full Text] [Related]
19. Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients.
Eady EA; Farmery MR; Ross JI; Cove JH; Cunliffe WJ
Br J Dermatol; 1994 Sep; 131(3):331-6. PubMed ID: 7918006
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
